KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic...

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Anaplastic thyroid carcinoma (ATC) is an aggressive thyroid cancer with poor prognosis.
• Understanding the molecular mechanisms driving ATC progression and chemoresistance is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the role of Krüppel-like factor 5 (KLF5) in ATC cell biological functions.
• To determine the effect of KLF5 on chemotherapy sensitivity in ATC.
• To elucidate the underlying molecular mechanisms, including the JNK signaling pathway.

Main Methods:

• KLF5 expression analysis in ATC cells versus normal thyroid cells.
• In vitro experiments involving KLF5 knockdown and overexpression in ATC cell lines.
• Assessment of cell proliferation, apoptosis, invasion, and migration.
• Analysis of multidrug resistance genes (MDR1/P-gp, ABCG2).
• Evaluation of JNK signaling pathway activation (p-JNK levels).

Main Results:

• KLF5 is upregulated in ATC cells.
• KLF5 knockdown inhibits ATC cell proliferation, invasion, and migration, while inducing apoptosis.
• KLF5 overexpression promotes proliferation and inhibits apoptosis, increasing resistance to doxorubicin (Dox).
• KLF5 knockdown enhances Dox sensitivity in ATC cells.
• KLF5 modulates the expression of MDR1/P-gp and ABCG2.
• KLF5 regulates JNK signaling pathway activation; KLF5 knockdown inactivates JNK.

Conclusions:

• KLF5 plays a significant role in promoting ATC cell proliferation, invasion, and migration.
• KLF5 knockdown enhances chemotherapy sensitivity in ATC, likely by inhibiting the JNK signaling pathway.
• Targeting KLF5 represents a potential therapeutic strategy for ATC treatment.